In early 2019, the AAPM Foundation brought
together a panel of pain management experts and patient advocates to develop
clear evidence-informed guidance for healthcare clinicians on the reduction or
elimination of opioids for those who are prescribed them chronically.
At the February 2020 AAPM Annual Meeting, members of that consensus panel presented key points from their discussions around the care of those on long-term, high-dose opioids, especially “legacy patients,” methods and ethics of compassionate management with extensive audience participation, criteria for maintaining vs. weaning, opioid use “gray zones,” and the role of buprenorphine.
The panel's findings will soon be published in a peer-reviewed journal.
AAPM Foundation Opioid Reduction Consensus Project Introduction
Charles Argoff, MD
High Dose Patients: Taper or Maintain?
Ajay Manhapra, MD
What Should Be Done About Dangerous Combinations
Michael Hooten, MD
When Is Referral Actually Abandonment?
Mark Sullivan, MD
Continue or Curtail, Consensual or Coercive: Who Decides?
Ed Covington, MD
How to Taper
Mark Sullivan, MD
Complex Persistent Dependence
Jane Ballantyne, MD FRCA
Fiscal Responsibility Versus Duties as Healers
Steven Stanos, DO
A Balancing Act: Tools to Help Taper
Jennifer Murphy, PhD
- Determine whether and how to reduce opioids.
- Develop and implement a plan for comfortable opioid and sedative reduction.
- Effectively manage those who, despite no opioid use disorder, respond poorly to both opioid escalation and reduction.
Fee: Members - $0, Non-Member - $25
This is a non-CME program.
© 2020 American Academy of Pain Medicine, 8735 West Higgins Road, Suite 300, Chicago, Illinois 60631
All rights reserved, including that of translation into other languages. No part of this on demand course may be shared, reproduced or transmitted in any form or by any means, electronic or mechanical, including printing, photocopying, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.